Niva Bupa Health Insurance Company Limited (NSE:NIVABUPA)
78.09
-2.14 (-2.67%)
Sep 24, 2026, 10:20 AM IST
NSE:NIVABUPA Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, NSE:NIVABUPA stock has a consensus rating of "Buy" and an average price target of ₹99.36. The average 1-year stock price forecast is 27.24% higher than the current stock price, while the lowest is ₹90.00 (+15.25%) and the highest is ₹105.00 (+34.46%).
Price Target: ₹99.36 (+27.24%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Jul 31, 2026.
Analyst Ratings
The average analyst rating for NSE:NIVABUPA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 3 |
| Buy | 5 | 5 | 5 | 6 | 6 | 7 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹100.00 → ₹105.00 | Buy | Maintains | ₹100.00 → ₹105.00 | +34.46% | Jul 31, 2026 |
| Motilal Oswal | Motilal Oswal | Buy Maintains ₹100.00 | Buy | Maintains | ₹100.00 | +28.06% | Jun 19, 2026 |
Financial Forecast
Revenue This Year
98.30B
from 84.43B
Increased by 16.42%
Revenue Next Year
121.62B
from 98.30B
Increased by 23.72%
EPS This Year
2.62
from 0.71
Increased by 269.65%
EPS Next Year
3.39
from 2.62
Increased by 29.13%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.